A study to check how well a hair serum, alone or with gummies, works compared to a placebo in reducing hair fall and helping hair grow in men and women

A Randomized, Placebo-Controlled, Parallel-Group Comparative Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Alone and in Combination with Gummies, Compared to Placebo, in Reducing Hair Fall and Promoting Hair Growth in Male and Female Participants. - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093853

Enrollment

105

Registered

2025-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair serum: Apply 1ml of the serum directly to the entire scalp and massage for two minutes. Keep overnight or minimum of 6 hours Use it twice daily Once in the morning and again at

Eligibility

Inclusion criteria

Inclusion criteria: 1. Trial participants in the age group 18-40 years. 2. Female and male trial participants in the ratio 7:3 in all three groups. 3. Trial participants willing to undergo shaving of a test area on the scalp and have a mark in the target area. 4. Trial participants able to read, understand, and provide informed consent. 5. Trial participants willing to give a written informed consent and willing to abide by and comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1. Trial participants who have undergone any kind of hair growth treatment in the last 3 months 2. Trial participants having any active scalp disease which may interfere with the study 3. Prior use of scalp hair growth treatment within 6 months. 4. Trial participants who have taken chemotherapy for cancer in the 6 months prior to the study start. 5. Trial participants who have undergone hair transplant.

Design outcomes

Primary

Measure	Time frame
1. To evaluate and compare hair growth from baseline at all subsequent time points in trial participants receiving Hair Serum alone, Hair Serum combined with Hair Vitamin Gummies, and Placebo, as measured by TrichoScan. 2. To evaluate and compare hair density from baseline at all subsequent time points in participants receiving Hair Serum alone, Hair Serum combined with Hair Vitamin Gummies, and Placebo, as measured by TrichoScan. 3. To evaluate and compare change in anagen to telogen ratio (A/T ratio) at day 86 in comparison to baseline as measured by TrichoScanTimepoint: Week 0, Week 4, Week 8, Week 12	—

Measure

Time frame

1. To evaluate and compare hair growth from baseline at all subsequent time points in trial participants receiving Hair Serum alone, Hair Serum combined with Hair Vitamin Gummies, and Placebo, as measured by TrichoScan. 2. To evaluate and compare hair density from baseline at all subsequent time points in participants receiving Hair Serum alone, Hair Serum combined with Hair Vitamin Gummies, and Placebo, as measured by TrichoScan. 3. To evaluate and compare change in anagen to telogen ratio (A/T ratio) at day 86 in comparison to baseline as measured by TrichoScanTimepoint: Week 0, Week 4, Week 8, Week 12

—

Secondary

Measure	Time frame
1. To evaluate hair fall by comb test in comparison to baseline and all defined time points. 2. To evaluate reduction in hair thinning using standard photo numeric scale (1-10) in comparison to baseline and all defined time points. 3. To evaluate hair thickness assessment using Caselite software in comparison to baseline and all defined time points. 4. To evaluate and compare change in hair growth by Dermatological assessment and Participant self assessment at all defined time points.Timepoint: Week 0, Week 4, Week 8, Week 12	—

Measure

Time frame

1. To evaluate hair fall by comb test in comparison to baseline and all defined time points. 2. To evaluate reduction in hair thinning using standard photo numeric scale (1-10) in comparison to baseline and all defined time points. 3. To evaluate hair thickness assessment using Caselite software in comparison to baseline and all defined time points. 4. To evaluate and compare change in hair growth by Dermatological assessment and Participant self assessment at all defined time points.Timepoint: Week 0, Week 4, Week 8, Week 12

—

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917253

Outcome results